RenovaCare, Inc., released behind–the–scenes video footage of its medical device for spraying a patient’s own stem cells onto burns and wounds for rapid self-healing. The footage includes compelling first-hand testimony and before-and-after images of a State Trooper’s rapid, scar-free recovery from severe burns to over one-third of his body.
RenovaCare, Inc., today announced positive spray test results demonstrating that its novel SkinGun™ technology achieves exceptionally-uniform distribution of fluids with 200 times greater coverage than conventional methods. These outcomes are especially promising to scientists developing patented RenovaCare CellMist™ and SkinGun™ technologies* for spraying fluids containing a patient’s own stem cells onto burns and wounds for rapid scar-free healing.
New York & Pittsburgh – May 3, 2016 – RenovaCare, Inc., (OTCQB: RCAR), a developer of novel medical grade liquid spray devices and patented CellMist™ and SkinGun™ technologies*, today announced favorable outcomes from laboratory studies conducted by Berlin-Brandenburg Center for Regenerative Therapies (BCRT), a translational research center at Charité – Universitätsmedizin Berlin, one of the…
New York & Pittsburgh – April 12, 2016 – RenovaCare, Inc., a developer of novel medical grade liquid spray devices and patented CellMist™ and SkinGun™ technologies* for isolating and spraying a patient’s own stem cells onto burns and wounds for rapid self-healing, today announced that the company has successfully completed the engineering, studies, and associated efforts…
New York & Pittsburgh – February 9, 2016 – RenovaCare, Inc., developer of patented CellMist™ and SkinGun™ technologies* for isolating and spraying a patient’s own stem cells onto burns and wounds for rapid self-healing, today announced the appointment of Steven Q. Wang to its Board of Advisors. Dr. Wang is Head of Dermatology Section and…
New York & Pittsburgh – January 12, 2016 – RenovaCare, Inc., developer of the patented CellMist™ and SkinGun™ technologies* for isolating and spraying a patient’s own stem cells onto burns and wounds for rapid self-healing, today announced the appointment of board certified plastic and reconstructive surgeon, Richard Simman, MD, FACS, and FACCWS, to its Board…
New York & Pittsburgh, PA – November 17, 2015 – RenovaCare, Inc. (OTCQB: RCAR), today announced a partnership to validate the science behind its groundbreaking technology for treatments of wounds, burns and other skin defects. The company’s research partner is Berlin-Brandenburg Center for Regenerative Therapies (BCRT), a translational research center at Charité – Universitätsmedizin Berlin,…
RenovaCare, Inc., (RCAR), developer of the patented CellMist™ and SkinGun™ technologies for isolating and spraying a patient’s own stem cells onto burns and wounds for rapid self-healing, today announced the appointment of healthcare executive and industry thought-leader, Michael M. Barch, to its Board of Advisors. Barch currently serves as Chairman of the Board of the…
Great ideas need great people to bring them to life. With this establishing principle, RenovaCare has assembled a highly skilled team of experienced managers and executives dedicated to advancing its CellMist™ System and related medical technologies. Since organizing as a medical device company, we have built a team with diverse backgrounds in commercial medical technology,…
The SkinGun™ is profiled on National Geographic. Click here to watch the video at natgeo.com (opens in a new tab or window). RenovaCare’s patented SkinGun™ spray device is the world’s most advanced technology of its kind. As part of our groundbreaking CellMist™ System, it has shown in early clinical observations in the United States and…